Brian E. Ward
Presidente en Advantage Genomics LLC .
Cargos activos de Brian E. Ward
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
American College of Medical Genetics & Genomics | Corporate Officer/Principal | - | - |
Advantage Genomics LLC | Presidente | 27/06/2011 | - |
Historial de carrera de Brian E. Ward
Antiguos cargos conocidos de Brian E. Ward.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DIADEXUS, INC. | Director/Miembro de la Junta | 17/05/2011 | 01/01/2015 |
Director Ejecutivo | 27/09/2011 | 01/01/2015 | |
Director de Operaciones | 30/06/2011 | 27/09/2011 | |
Independent Dir/Board Member | 17/05/2011 | 31/07/2012 | |
Presidente | 27/09/2011 | 08/04/2014 | |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Director de Operaciones | 01/05/2008 | 14/01/2014 |
Corporate Officer/Principal | 01/09/2010 | 06/12/2012 | |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | Corporate Officer/Principal | - | 03/11/2009 |
GENOMIC HEALTH, INC. | Corporate Officer/Principal | 01/02/2007 | - |
University of Colorado Health Sciences Center | Corporate Officer/Principal | - | - |
Genzyme Genetics, Inc.
Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Corporate Officer/Principal | - | - |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Director de Operaciones | - | - |
Formación de Brian E. Ward.
University of Colorado Health Sciences Center | Doctorate Degree |
University of Wisconsin | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 11 |
Operativa
Corporate Officer/Principal | 6 |
Chief Operating Officer | 3 |
President | 2 |
Sectorial
Health Services | 4 |
Consumer Services | 4 |
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 7 |
---|---|
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | Health Services |
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Commercial Services |
Genzyme Genetics, Inc.
Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Health Services |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Health Services |
Diadexus, Inc.
Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Advantage Genomics LLC |
- Bolsa de valores
- Insiders
- Brian E. Ward
- Experiencia